Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
2 years, 1 month ago

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1

News 18  

Over 7,000 doses of the world’s first intranasal Covid-19 vaccine, Bharat Biotech’s iNCOVACC, have been checked and released by the country’s apex vaccine testing laboratory, News18.com has learnt. BBV154, a novel adenovirus vectored intranasal vaccine for Covid-19, was sent to CDL in the first week of January in around six batches containing 15,000 doses. In polio, the dropper drops the vaccine into the mouth.” In December, the intranasal Covid-19 vaccine was approved by the Union Health Ministry as a booster dose for those aged 18 and above. “This vaccine received approval under restricted use in emergency situations for ages 18 and above for primary 2 dose schedule, homologous booster doses,” said the government release dated December 1.

Vaccine  market  bharat  vaccine  polio  week  ready  vial  jab  doses  officer  lab  rollout  clears  intranasal  union  biotechs  sent  covid19

History of this topic

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
6 months, 4 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university
7 months ago

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university

The Hindu  

Hyderabad-headquartered vaccine manufacturer Indian Immunologicals Ltd, in partnership with Griffith University, Australia has developed a needle-free intra-nasal booster vaccine against SARS-CoV-2, a press release from the company stated. According to the press release, codon de-optimisation involves decreasing the frequency of underrepresented codon pairs without changing the amino acid sequences. K. Anand Kumar, managing director, Indian Immunologicals Limited said as per …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year, 3 months ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 3 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 9 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 9 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India sees a surge in COVID-19 cases: Does the country need a fourth jab?
1 year, 11 months ago

India sees a surge in COVID-19 cases: Does the country need a fourth jab?

Firstpost  

India has registered 3,641 fresh cases of COVID-19 in the last 24 hours. Experts say taking a booster shot may not be very beneficial COVID-19 cases across several states in India are on the rise, thanks to XXB.1.16 – a subtype of Omicron, also a matter of concern. According to the health ministry data, India logged 3,641 new infections in …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
2 years ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India
2 years, 1 month ago

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India

Live Mint  

The world's first intranasal heterologous booster dose has begun to be dispatched by Bharat Biotech to hospitals, Executive Chairman Dr. Krishna Ella announced on February 5. He discussed the delivery of vaccines under the bilateral agreement between the Ella Foundation and the UW-Madison Global Health Institute for the establishment of the first-ever UW-Madison One Health Center in India for improving …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
2 years, 1 month ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Nasal vaccine at govt centres in Delhi from Feb 15
2 years, 2 months ago

Nasal vaccine at govt centres in Delhi from Feb 15

Hindustan Times  

India’s first nasal vaccine for Covid-19, iNCOVACC, which was formally launched on Thursday, is likely to be made available at government centres in the national capital by mid-February, senior officials of the Delhi government said on Friday. Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
2 years, 2 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

What is nasal vaccine - iNCOVACC? All you need to know
2 years, 2 months ago

What is nasal vaccine - iNCOVACC? All you need to know

India TV News  

Covid19 nasal vaccine : Union Health Minister Mansukh Mandaviya on Friday launched Bharat Biotech's first India-made nasal Vaccine, iNCOVACC, as a booster shot for Covid19. According to Bharat Biotech, the nasal vaccine is likely to prevent infection, thus, preventing the transmission of the virus. The event saw the Union Minister of State Science & Technology; Minister of State Earth Sciences; …

Centre rolls out first nasal Covid vaccine as booster
2 years, 2 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

iNCOVACC: Bharat Biotech launches world's first intranasal Covid vaccine on Republic Day
2 years, 2 months ago

iNCOVACC: Bharat Biotech launches world's first intranasal Covid vaccine on Republic Day

Op India  

As the country marked its 74th Republic Day, Union Health Minister Dr Mansukh Mandaviya and Union Science and Technology Minister Jitendra Singh launched Bharat Biotech’s first India-made nasal Covid-19 vaccine, iNCOVACC, on Thursday. “Bharat Biotech International Limited, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today dedicated iNCOVACC® to the nation, the world’s 1st COVID …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
2 years, 2 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

Private hospitals with advance orders to get intranasal COVID-19 shots soon
2 years, 2 months ago

Private hospitals with advance orders to get intranasal COVID-19 shots soon

The Hindu  

Union Health Minister Mansukh Mandaviya and Minister of Science and Technology Jitendra Singh launched first-of-it’s-kind intranasal COVID-19 vaccine iNCOVACC manufactured by Hyderabad-based Vaccine developer Bharat Biotech International Limited on January 26, 2023. It is the world’s first Intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose, administered as nasal drops. The …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
2 years, 2 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
2 years, 2 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
2 years, 2 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
2 years, 2 months ago

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26

Hindustan Times  

Bhopal: Bharat Biotech’s nasal Covid-19 vaccine iNCOVACC is expected to be launched on January 26, executive chairman Krishna Ella said at an event on Saturday. “Our nasal vaccine will be officially launched on January 26 on Republic Day,” Ella told students at the Maulana Azad National Institute of Technology in Bhopal, where the India International Science Festival, 2022, is being …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
2 years, 2 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
2 years, 2 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
2 years, 2 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

No second Covid-19 booster dose required: Report
2 years, 2 months ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
2 years, 3 months ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times  

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years, 3 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
2 years, 3 months ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years, 3 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years, 3 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
2 years, 3 months ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint  

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
2 years, 3 months ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

Nasal vaccines to roll out in private hospitals soon
2 years, 3 months ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years, 3 months ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years, 3 months ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose
2 years, 3 months ago

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose

India TV News  

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose Bharat Biotech nasal vaccine: According to reports, two drops of the vaccine can be treated as a dose. Bharat Biotech's needle-free intranasal Covid vaccine has been approved by the Centre as booster dose for those aged above 18, official sources said. Meanwhile, the Indian Medical Association has advised people to …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years, 3 months ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use
2 years, 3 months ago

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use

Live Mint  

World's first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation for restricted use in emergency situations in the age group of 18 and above. A press release from the vaccine maker said iNCOVACC, a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein, is the world's first …

More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine
2 years, 4 months ago

More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine

The Hindu  

Nearly three months after Bharat Biotech’s intranasal COVID-19 vaccine was granted emergency use approval for primary vaccination of adults, the vaccine has now been given emergency use approval as a heterologous booster in adults over 18 years. As in the case of the intranasal vaccine for primary vaccination, the booster dose too was tested only for safety and immunogenicity, but …

Bharat Biotech's intranasal vaccine gets approval as heterologous booster
2 years, 4 months ago

Bharat Biotech's intranasal vaccine gets approval as heterologous booster

India Today  

Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that iNCOVACC, has received approval from the Central Drugs Standard Control Organisation under Restricted Use in Emergency Situation for ages 18 and above, in India, for heterologous booster doses. Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech, said, “iNCOVACC, is an intranasal …

CDSCO nod for Bharat Biotech’s COVID-19 intranasal vaccine under restricted use
2 years, 4 months ago

CDSCO nod for Bharat Biotech’s COVID-19 intranasal vaccine under restricted use

The Hindu  

Bharat Biotech’s COVID-19 intranasal vaccine iNCOVACC has received Central Drugs Standard Control Organisation approval under restricted use in emergency situation for ages 18 and above for heterologous booster doses. Heterologous booster dose studies were conducted for safety and immunogenicity in about 875 subjects, with BBV154 intranasal vaccine administered post two doses of the two commonly administered COVID-19 vaccines. Product development …

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster
2 years, 4 months ago

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster

Live Mint  

Pharma firm Bharat Biotech on Monday announced that its intranasal covid-19 vaccine iNCOVACC has received approval from the Central Drugs Standard Control Organization for people above 18 years of age as a heterologous booster dose under restricted emergency use in India. With this development, INCOVACC becomes world’s first intranasal vaccine to receive both primary series and heterologous booster approval, the …

Scared of needles? Oral Covid vaccine to roll out soon | Details
2 years, 5 months ago

Scared of needles? Oral Covid vaccine to roll out soon | Details

India TV News  

Oral Covid vaccine to roll out soon | Details Covid19: A vaccine taken orally could fend off the virus before it reaches the rest of the respiratory system, though that would depend in part on the size of the droplets, an expert said. Chinese regulators approved the inhalable one in September, but only as a booster shot after studies showed …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 5 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 5 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 5 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 6 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 6 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 6 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

Discover Related